Dina Visca to Tuberculosis
This is a "connection" page, showing publications Dina Visca has written about Tuberculosis.
Connection Strength
1.055
-
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021 Mar-Apr; 27(2):151-165.
Score: 0.278
-
Tuberculosis in the time of COVID-19: quality of life and digital innovation. Eur Respir J. 2020 08; 56(2).
Score: 0.269
-
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019 03; 53(3).
Score: 0.244
-
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 2021 May-Jun; 27(3):248-256.
Score: 0.069
-
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
Score: 0.068
-
Tuberculosis elimination: where are we now? Eur Respir Rev. 2018 Jun 30; 27(148).
Score: 0.058
-
World TB Day 2017: Strengthening the fight against TB. Presse Med. 2017 Mar; 46(2 Pt 2):e1-e4.
Score: 0.053
-
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
Score: 0.017